FIELD: chemistry.
SUBSTANCE: invention refers to anhydrous polymorphic salt representing hemisulphate 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxymethyl)-1-(R)-cycloamyl]- cytosine of formula (Ia) possessing extra stability and improved physical properties that facilitates production, transportation of compound and preparation of compositions on the basis of compounds of formula I . Invention also refers to various crystal forms of compounds of formula (Ia), characterised by certain values of lattice constant D (interplanar spacing), to methods of their production from compounds of formula (I), to pharmaceutical compositions on the basis of compounds of formula (Ia) and to method of disease treatment caused by C hepatitis virus, including injection if such treatment is required, of therapeutically effective amount of compound of formula (Ia).
EFFECT: production of compound possessing extra stability and improved physical properties that facilitates production, transportation of compound and preparation of compositions on its basis.
14 cl, 5 dwg, 1 tbl, 9 ex
Title |
Year |
Author |
Number |
METHOD OF MODIFYING CRYSTALLISATION PROCESS OF MEDICINAL SUBSTANCE |
2004 |
- Pfeffer Zabine
- Vikkkhuzen Dirk
|
RU2388757C2 |
POLYMORPHOUS AND AMORPHOUS FORMS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINE[5,4,3-CD]INDOL-6-ON PHOSPHATE |
2005 |
- Liu Dzhia
- Najjar Naresh
- Guo Ming
- Vu Zhen-Ping
- Borer Bennett Shaplin
- Shrirangam Aparna Nadig
- Mitchell Mark Brajan
- Li Ji
- Chu Dzhan-Dzhon
|
RU2355691C2 |
SOLID FORMS OF THE COMPOUND MODULATING THE KINASES |
2016 |
- Ibrakhim Prabkha N.
- Vajzor Geri Konrad
|
RU2730506C2 |
CRYSTALLINE POLYMORPHOUS FORM OF THROMBIN RECEPTOR ANTAGONIST BISULFATE |
2005 |
- Tiruvengadam Tiruvettipuram K.
- Vu Venksue
- Vang Tao
- Chiu Dzhon S.
- Bogdanovich-Knipp S'Juzan
- Pavlovski Anastasija
- Grinli Uilliam Dzh.
- Graziano Majkl P.
- Kosoglou Tehddi
- Chintala Madkhu
- Chakalamannil Samuehl'
|
RU2355689C9 |
CRYSTALLINE FORM AND TOSYLATE OF TETRACYCLINE COMPOUND, CRYSTALLINE FORM OF SAID TOSYLATE AND POLYMORPH THEREOF, METHOD OF PRODUCING TOSYLATE OF TETRACYCLINE COMPOUND, POLYMORPH OBTAINED USING SAID METHOD, AND PHARMACEUTICAL COMPOSITIONS BASED ON SAID CRYSTALLINE FORM AND POLYMORPH |
2009 |
- Uorchol Tadeush
- Tsvetovich Rajmond
|
RU2500665C2 |
SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-cd]INDOL-6-ONE |
2011 |
- Patrishija Ehnn Basford
- Antoni Majkl Kampeta
- Adam Dzhillmor
- Matt'Ju Kameron Dzhons
- Ehlefterois Kougoulos
- Suman Lutra
- Robert Uolton
|
RU2570198C2 |
SALTS AND POLYMORPHIC MODIFICATIONS OF THE INHIBITOR VEGF-R |
2006 |
- Li I
- Lju Tszja
- Sistla Anand
- Ehlder Brjus Dzhozef
- Khun Jujfyn
- Izbester Pol Kennet
- Palmer Grant Dzhekson
- Sehlsberi Dzhonatan Stjuart
- Juliss Lakner Dzherard
|
RU2369607C1 |
METHODS OF PRODUCTION ISOQUINOLINONES AND SOLID FORMS ISOQUINOLINONES |
2012 |
- Zhen Pinda
- Martin Majkl
- Izbester Pol
- Lejn Bendzhamin S.
- Kropp Dzhejson
|
RU2626883C2 |
SOLID FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR |
2013 |
|
RU2673077C2 |
CRYSTALLINE FORMS OF 1-(5'-(5-(3,5-DICHLORO-4-FLUOROPHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDROISOXAZOL-3-YL)-3'H-SPIRO[AZETIDINE-3,1'-ISOBENZOFURAN]-1-YL)-2-(METHYLSULFONYL)ETHANONE |
2013 |
- Billen Denis
- Bechmejer Metyu Dzhozef
- Vanderroest Ronald Dzhej
|
RU2614978C2 |